Such audits consider the records and documentation related to the manufacture of medicines, the quality management system (manuals, risk assessment, control of change, technology transfer, among others), qualified personnel, facilities and equipment (areas of production and storage); manufacturing system (control of inputs, sampling, reception and supply), control of the products’ conditioning, distribution control, final waste disposal, pharmacovigilance, contractors and returns.